Effect of MBCP block as carrier of rhBMP-2 in combination with ePTFE membrane on bone formation in rat calvarial defects

  • Shin, Chul-Woo (Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University) ;
  • Cho, Kyoo-Sung (Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University) ;
  • Jung, Sung-Won (Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University) ;
  • Kim, Chang-Sung (Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University) ;
  • Choi, Seong-Ho (Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University) ;
  • Yun, Jeong-Ho (Department of Dentistry, College of Medicine, Kwandong University, Myongji Hospital)
  • Published : 2008.08.15

Abstract

Purpose: The carrier used as delivery agent for bone morphogenetic proteins(BMPs) should also act as a scaffold for new bone formation. Moreover, bone formation should be predictable in terms of the volume and shape. This study examined the osteogenic effect of macroporous biphasic calcium phosphate (MBCP) block combined with ePTFE membrane as a carrier for recombinant human bone morphogenetic proteins (rhBMP-2). In addition, the additive effect of ePTFE membrane on bone formation was evaluated. Materials and Methods: Eight-millimeter critical sized calvarial defects were created surgically in 28 male Sprague-Dawley rats. The animals were divided into 2 groups containing 14 animals each. The defects were treated with either rhBMP-2/MBCP block (rhBMP-2/MBCP group) or rhBMP-2/MBCP block/ePTFE membrane (rhBMP-2/MBCP/ePTFE group). A disc-shaped MBCP block (3 mm height and 8 mm diameter) was used as the carrier for the rhBMP-2 and ePTFE membrane was used to cover the rhBMP-2/MBCP block. The histologic and histometric parameters were used to evaluate the defects after 2- or 8-week healing period (7 animals/group/healing interval). Results: The level of bone formation in the defects of both groups was significantly higher at 8 weeks than that at 2 weeks (P < 0.05). The ePTFE membrane has no additional effect compared with the rhBMP-2/MBCP block only. However, at 8 weeks, rhBMP-2/MBCP/ePTFE group showed more even bone formation on the top of the MBCP block than the rhBMP-2/MBCP group. Conclusion: These results suggest that the ePTFE membrane has no additive effect on bone formation when a MBCP block is used as a carrier for rhBMP-2.

Keywords

References

  1. Cordaro L, Amade DS, Cordaro M. Clinical results of alveolar ridge augmentation with mandibular block bone grafts in partially edentulous patients prior to implant placement. Clin Oral Implants Res 2002;13:103-111. https://doi.org/10.1034/j.1600-0501.2002.130113.x
  2. Aldinger G, Herr G, Kusswetter W, et al. Bone morphogenetic protein: a review. Int Orthop 1991;15: 169-177.
  3. Urist MR. Bone: Formation by autoinduction. Science 1965;150:893-899. https://doi.org/10.1126/science.150.3698.893
  4. Hughes FJ, Collyer J, Stanfield M, Goodman SA. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 1995;136:2671-2677. https://doi.org/10.1210/en.136.6.2671
  5. Hyun SJ, Choi SH, Chai JK, et al. The effect of recombinant human bone morphogenetic protein-2, 4 and 7 on bone formation in rat calvarial defects. J Periodontol 2005;76:1667-1674. https://doi.org/10.1902/jop.2005.76.10.1667
  6. Kim CS, Kim JI, Kim J, et al. Ectopic bone formation associated with recombinant human bone morphogenetic protein-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. Biomaterials 2005;26;2501-2507. https://doi.org/10.1016/j.biomaterials.2004.07.015
  7. Miranda DA, Blumenthal NM, Sorensen RG, Wozney JM, Wikesjo UM. Evaluation of recombinant human bone morphogenetic protein-2 on the repair of alveolar ridge defects in baboons. J Periodontol 2005;76:210-220. https://doi.org/10.1902/jop.2005.76.2.210
  8. Lindholm TS, Gao TJ. Functional carriers for bone morphogenetic proteins. Ann Chir Gynaecol Suppl 1993;207:3-12.
  9. Ahn SH, Kim CS, Suk HJ, et al. Effect of recombinant human bone morphogenetic protein- 4 with carriers in rat calvarial defects. J Periodontol 2003;74:787-797. https://doi.org/10.1902/jop.2003.74.6.787
  10. Choi SH, Kim CK, Cho KS, et al. Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs. J Periodontol 2002;73:63-72. https://doi.org/10.1902/jop.2002.73.1.63
  11. Jung UW, Choi SY, Pang EK, et al. The effect of varying the particle size of beta tricalcium phosphate carrier of recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J Periodontol 2006;77: 765-772. https://doi.org/10.1902/jop.2006.050268
  12. Han DK, Kim CS, Jung UW, et al. Effect of a fibrin-fibronectin sealing system as a carrier for recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J Periodontol 2005;76:2216-2222. https://doi.org/10.1902/jop.2005.76.12.2216
  13. Hong SJ, Kim CS, Han DK, et al. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects. Biomaterials 2006;27:3810-3816. https://doi.org/10.1016/j.biomaterials.2006.02.045
  14. Lee YJ, Jung SW, Chae GJ Cho KS, Kim CS. The effect of recombinant human bone morphogenetic protein-2/macroporous biphasic calcium phosphate block system on bone formation in rat calvarial defects. J Kor Acad Periodontol 2007;37:397-407. https://doi.org/10.5051/jkape.2007.37.Suppl.397
  15. Nery EB, LeGeros RZ, Lynch KL, Lee K. Tissue response to biphasic calcium phosphate ceramic with different ratios of HA/ß-TCP in periodontal osseous defects. J Periodontol 1992;63:729-735. https://doi.org/10.1902/jop.1992.63.9.729
  16. Gauthier O, Bouler JM, Aguado E, Pilet P, Daculsi G. Macroporous biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone ingrowth. Biomaterials 1998;19:133-139. https://doi.org/10.1016/S0142-9612(97)00180-4
  17. LeGeros RZ, Lin S, Rohanizadeh R, Mijares D, LeGeros JP. Biphasic calcium phosphate bioceramics: preparation, properties and applications. J Mater Sci Mater Med 2003;14:201-209. https://doi.org/10.1023/A:1022872421333
  18. Linde A, Alberius P, Dahlin C, Bjurstam K, Sundin Y. Osteopromotion: a soft tissue exclusion principle using a membrane for bone healing and bone neogenesis. J Periodontol 1993;64:1116-1128. https://doi.org/10.1902/jop.1993.64.11s.1116
  19. Linde A, Hedner E. Recombinant bone morphogenetic protein-2 enhances bone healing, guided by osteopromotive ePTFE membranes: an experimental study in rats. Calcif Tissue Int 1995;56:549-553. https://doi.org/10.1007/BF00298588
  20. Zellin G, Hedner E, Linde A. Bone regeneration by a combination of osteopromotive membranes with different BMP preparations: a review. Connect Tissue Res 1996;35:279-284. https://doi.org/10.3109/03008209609029202
  21. Zellin G, Linde A. Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects. J Biomed Mater Res 1997;35: 181-190. https://doi.org/10.1002/(SICI)1097-4636(199705)35:2<181::AID-JBM6>3.0.CO;2-J
  22. Gordh M, Alberius P, Johnell O, Lindberg L, Linde A. Effects of rhBMP-2 and osteopromotive membranes on experimental bone grafting. Plast Reconstr Surg 1999;103: 1909-1918. https://doi.org/10.1097/00006534-199906000-00016
  23. Wikesjo UM, Xiropaidis AV, Thomson RC, et al. Periodontal repair in dogs: space-providing ePTFE devices increase rhBMP-2/ACS-induced bone formation. J Clin Periodontol 2003;30:715-725. https://doi.org/10.1034/j.1600-051X.2003.00364.x
  24. Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunins. Clin Orthop Relat Res 1986;205:299-308.
  25. Le Nihouannen D, Daculsi G, Saffarzadeh A, et al. Ectopic bone formation by microporous calcium phosphate ceramic particles in sheep muscles. Bone 2005;36:1086-1093. https://doi.org/10.1016/j.bone.2005.02.017
  26. Habibovic P, Yuan H, van den Doel M, et al. Relevance of osteoinductive biomaterials in critical-sized orthotopic defect. J Orthop Res 2006;24:867-876.
  27. Manjubala I, Sastry TP, Kumar RV. Bone in-growth induced by biphasic calcium phosphate ceramic in femoral defect of dogs. J Biomater Appl 2005;19:341-360. https://doi.org/10.1177/0885328205048633
  28. Daculsi G, Passuti N, Martin S, et al. Macroporous calcium phosphate ceramic for long bone surgery in humans and dogs. Clinical and histological study. J Biomed Mater Res 1990;24:379-396. https://doi.org/10.1002/jbm.820240309
  29. Scantlebury TV. 1982-1992: a decade of technology development for guided tissue regeneration. J Periodontol. 1993;64:1129-1137. https://doi.org/10.1902/jop.1993.64.11s.1129
  30. Zellin G, Linde A. Effects of different osteopromotive membrane porosities on experimental bone neogenesis in rats. Biomaterials. 1996;17:695-702. https://doi.org/10.1016/0142-9612(96)86739-1
  31. Wikesjo UM, Lim WH, Thomson RC, Hardwick WR. Periodontal repair in dogs: gingival tissue occlusion, a critical requirement for GTR J Clin Periodontol. 2003;30: 655-664. https://doi.org/10.1034/j.1600-051X.2003.00362.x
  32. Polimeni G, Koo KT, Qahash M, et al. Prognostic factors for alveolar regeneration: effect of tissue occlusion on alveolar bone regeneration with guided tissue regeneration. J Clin Periodontol. 2004;31:730-735. https://doi.org/10.1111/j.1600-051X.2004.00543.x